Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
[ad_1]
The snack aisle is seen during a tour of a new Amazon Go store in the Capitol Hill neighborhood of Seattle, Washington, U.S., on Monday, Feb. 24, 2020. Chona Kasinger | Bloomberg | Getty Images For more than a century, frosted cornflakes have been the backbone of Kellogg's business. That changes Monday, when the company will spin off its stable cereal business in favor of its faster-growing snack unit and rename itself Kellanova . The spinoff comes weeks after another wager that consumers will graze between meals, when J.M. Smucker bought Twinkie maker Hostess Brands for $5.6 billion in a bid to expand its snack lineup. But food companies' major bets on snacking come as investors fear the looming danger of Big Pharma's blockbuster obesity and diabetes drugs Wegovy and Ozempic. Many investors have high hopes for the pharmaceuticals' future, but their success could mean slower sales for the companies that produce Oreos, Doritos and Hershey's Kisses. Bi